phase readout
saveNCT07210632: Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
RECRUITINGupdated 23h ago
community read0 votes
Sponsor: Eben Rosenthal. Phase: EARLY_PHASE1. Conditions: Brain Cancer, HGG, Glioma, High Grade Glioma, High Grade Gliomas, High Grade Glioma (III or IV), High Grade Glioma (HGG) of the Brain With BRAF Aberration
view source ↗
comments(0)
5-min edit window · permanent after that